AI Medical Devices Need a Post-Market Monitoring Plan
AI medical devices become a durable healthcare market when performance, drift, complaints, and clinical context remain visible after deployment.
Global Healthcare News tracks the business signals behind care delivery, policy, life sciences, health technology, devices, diagnostics, and market movement.
AI medical devices become a durable healthcare market when performance, drift, complaints, and clinical context remain visible after deployment.
Provider operations, staffing, and delivery models across hospitals and care networks.
Digital infrastructure, workflow software, analytics, and security.
Devices, diagnostics, and the systems that support clinical workflows.
Drug development, manufacturing, approval cycles, and market movement.
Testing, certification, and quality systems across healthcare and adjacent markets.
Laboratory science, commercialization, and industry structure.
Equipment, machinery, and infrastructure supporting healthcare operations.
Biotech platforms, pipelines, and commercialization signals.
Medical device traceability is stronger when identifiers, product records, locations, and post-market actions can be joined without manual guesswork.
Antimicrobial stewardship becomes operational when prescribing decisions, diagnostic evidence, resistance patterns, and feedback return to the clinical team.
Cancer screening capacity is not the number of tests offered. It is the complete route from an eligible person to a timely result, diagnosis, treatment, and follow-up.
Health equity metrics become useful when a health system defines the population, measures access and outcomes consistently, and assigns someone to act on the gap.
Laboratory quality management is strongest when the full testing pathway is documented, controlled, reviewed, and compared with an external reference.
Pharmacovigilance signal detection becomes more useful when a suspected safety pattern has a clear case definition, denominator, evidence trail, and review owner.
Palliative care access is shaped by referral timing, workforce, medicine availability, communication, and continuity across settings, not by specialist clinic count alone.
Climate-resilient hospitals protect care continuity by planning for workforce, water, energy, infrastructure, technology, products, and the communities they serve.
Reproductive health data systems need a clear purpose, minimum necessary collection, access controls, retention rules, and an honest account of who can see the record.
Wearable health data becomes clinically useful only when the measurement, population, intended decision, device limitations, and follow-up action are defined.